Search
Search
About
Log in
Join
Experiences with
Jakavi
Posts
Communities
209 public posts
Filter results
Ruxolitinib at last
At long last I have been approved to commence
Jakavi
. Has anyone with PV and possible von Willibrands had experience of transitioning to
Jakavi
. All advice appreciated.
At long last I have been approved to commence
Jakavi
. Has anyone with PV and possible von Willibrands had experience of transitioning to
Jakavi
. All advice appreciated.
hackett
in
MPN Voice
9 years ago
pv ,mf1 ,jak2 positiv,jakavi,femal,
,first treatment phlebotomies later hu.in2015 my illness progressed:if felt more exhausted and had temperature for weeks .a second bone marrow biobsy showed pv and mf1.now it take
jakavi
and feeling better.i am63 and decided this year to stop my work as adoctor for paediatrics in order to have less
,first treatment phlebotomies later hu.in2015 my illness progressed:if felt more exhausted and had temperature for weeks .a second bone marrow biobsy showed pv and mf1.now it take
jakavi
and feeling better.i am63 and decided this year to stop my work as adoctor for paediatrics in order to have less
angelikadrschell25
in
MPN Voice
9 years ago
From PV and MF to Myloproliferative disorder?
Hello, I hope one of the experts or doctors can answer this question. I have PV & MF and taking Jakafi 25mg twice daily. I had to go to another oncologist recently who said my counts looked good so I was in a type of remission and now I'm just nyloproliferative disorder. But she said to keep taking
Hello, I hope one of the experts or doctors can answer this question. I have PV & MF and taking Jakafi 25mg twice daily. I had to go to another oncologist recently who said my counts looked good so I was in a type of remission and now I'm just nyloproliferative disorder. But she said to keep taking
fiddlelady
in
MPN Voice
9 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
Ruxolitinib (Jakavi) for the treatment of Myelofibrosis (MF) - Accepted for use in NHS Scotland
The SMC have announced this month that they have approved Ruxolitinib (
Jakavi
) for the treatment of MF, and therefore this medication can now be prescribed to patients via NHS Scotland, it has previously only been available to patients after a specific individual application for exceptional funding
The SMC have announced this month that they have approved Ruxolitinib (
Jakavi
) for the treatment of MF, and therefore this medication can now be prescribed to patients via NHS Scotland, it has previously only been available to patients after a specific individual application for exceptional funding
Mazcd
MPNVoice
in
MPN Voice
9 years ago
WAITING FOR MY 'GOLDEN TICKET'
Hi Guys, as some of you will be aware I have been having an uphill struggle to be put onto Ruxolitinib. Well Im pleased to say the day has finally arrived. And as you may also recall I have my own way of recording such milestones so I have penned a few lines to share my experience of it with you. And
Hi Guys, as some of you will be aware I have been having an uphill struggle to be put onto Ruxolitinib. Well Im pleased to say the day has finally arrived. And as you may also recall I have my own way of recording such milestones so I have penned a few lines to share my experience of it with you. And
JediReject
in
MPN Voice
10 years ago
Ruxolitinib - patient & family/carer questionnaires
We need your help and feedback to support an application to the Scottish Medicines Consortium (SMC) for the prescribing of Ruxolitinib (
Jakavi
) to patients living in Scotland Ruxolitinib (
Jakavi
) as a treatment for disease related splenomegaly (enlarged spleen) or symptoms in adults with primary myelofibrosis
We need your help and feedback to support an application to the Scottish Medicines Consortium (SMC) for the prescribing of Ruxolitinib (
Jakavi
) to patients living in Scotland Ruxolitinib (
Jakavi
) as a treatment for disease related splenomegaly (enlarged spleen) or symptoms in adults with primary myelofibrosis
Mazcd
MPNVoice
in
MPN Voice
10 years ago
Ruxolitinib (Jakavi) change to packaging
Novartis Pharmaceuticals UK Limited have informed MPD Voice that as of Friday 16th August 2013,
Jakavi
(Ruxolitinib) tablets will be packaged in blister packs, the formulation of the tablets will remain the same, it is just the packaging that has changed.
Novartis Pharmaceuticals UK Limited have informed MPD Voice that as of Friday 16th August 2013,
Jakavi
(Ruxolitinib) tablets will be packaged in blister packs, the formulation of the tablets will remain the same, it is just the packaging that has changed.
Mazcd
MPNVoice
in
MPN Voice
11 years ago
Ruxolitinib as a treatment for Myelofibrosis (MF) – NICE draft guidance - UPDATE
Further to the NICE draft guidance not recommending Ruxolitinib (
Jakavi
, Novartis), for the treatment of disease-related splenomegaly (enlarged spleen) or symptoms in adults with primary myelofibrosis, or myelofibrosis secondary to polycythaemia vera or essential thrombocythaemia.
Further to the NICE draft guidance not recommending Ruxolitinib (
Jakavi
, Novartis), for the treatment of disease-related splenomegaly (enlarged spleen) or symptoms in adults with primary myelofibrosis, or myelofibrosis secondary to polycythaemia vera or essential thrombocythaemia.
Mazcd
MPNVoice
in
MPN Voice
11 years ago
Has anyone out there been fortunate enough to get on to the JAKAFI trials........
Joprv
in
MPN Voice
12 years ago
1
...
10
11
10
Filter results
Clear filters
Posted in
All communities
MPN Voice
199 results
Fight MPN
6 results
CLL Support
4 results
Sort by
Most Relevant
Newest